These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26461001)

  • 21. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
    Fenton BM; Paoni SF; Ding I
    Cancer Res; 2004 Aug; 64(16):5712-9. PubMed ID: 15313911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
    Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
    Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma.
    Xian J; Yang H; Lin Y; Liu S
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1079-85. PubMed ID: 16365221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
    Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
    Lew YS; Kolozsvary A; Brown SL; Kim JH
    Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft.
    Znati CA; Rosenstein M; Boucher Y; Epperly MW; Bloomer WD; Jain RK
    Cancer Res; 1996 Mar; 56(5):964-68. PubMed ID: 8640786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay.
    Amano M; Suzuki M; Andoh S; Monzen H; Terai K; Williams B; Song CW; Mayo KH; Hasegawa T; Dings RP; Griffin RJ
    Int J Clin Oncol; 2007 Feb; 12(1):42-7. PubMed ID: 17380440
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Cai Z; Liu R; Chan C; Lu Y; Winnik MA; Cescon DW; Reilly RM
    Mol Pharm; 2022 Nov; 19(11):4199-4211. PubMed ID: 36287201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
    Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
    Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor.
    Jiang J; Bischof J
    Cryo Letters; 2010; 31(1):50-62. PubMed ID: 20309509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
    Liu S; Yang H; Liang C
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors.
    Azria D; Larbouret C; Garambois V; Gourgou S; Martineau P; Robert B; Dubois JB; Pelegrin A
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):580-8. PubMed ID: 14751531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
    Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
    Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
    Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
    Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
    Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.